Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gonzalo Diaz-Soto

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Diabetes and Its Complications|April 1, 2015
Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptorDaniel Antonio de Luis, Gonzalo Diaz Soto, Olatz Izaola, et al.
Endocrine|May 15, 2013
Primary hyperparathyroidism in pregnancyGonzalo Diaz-Soto, Agnès Linglart, Marie-Victoire Sénat, et al.
Journal of Clinical Laboratory Analysis|September 25, 2012
Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidismDaniel Antonio de Luis, Gonzalo Diaz Soto, Rosa Conde, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 11, 2013
Role of genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) on weight loss and cardiovascular risk factors after liraglutide treatment in obese patients with diabetes mellitus type 2Daniel Antonio de Luis, Hilda F Ovalle, Gonzalo Diaz Soto, et al.
Journal of Diabetes Science and Technology|April 26, 2022
Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With DiabetesVirginia Bellido, Eva Aguilera, Roque Cardona-Hernandez, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2022
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 CasesIulia Potorac, Jean-François Bonneville, Adrian F Daly, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Diabetes and Its Complications|April 1, 2015
Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptorDaniel Antonio de Luis, Gonzalo Diaz Soto, Olatz Izaola, et al.
Endocrine|May 15, 2013
Primary hyperparathyroidism in pregnancyGonzalo Diaz-Soto, Agnès Linglart, Marie-Victoire Sénat, et al.
Journal of Clinical Laboratory Analysis|September 25, 2012
Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidismDaniel Antonio de Luis, Gonzalo Diaz Soto, Rosa Conde, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 11, 2013
Role of genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) on weight loss and cardiovascular risk factors after liraglutide treatment in obese patients with diabetes mellitus type 2Daniel Antonio de Luis, Hilda F Ovalle, Gonzalo Diaz Soto, et al.
Journal of Diabetes Science and Technology|April 26, 2022
Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With DiabetesVirginia Bellido, Eva Aguilera, Roque Cardona-Hernandez, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2022
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 CasesIulia Potorac, Jean-François Bonneville, Adrian F Daly, et al.
Pageof 1